ICICI Securities has maintained a Buy rating on Suzlon Energy, retaining an unchanged target price of Rs 65, implying 35% upside from the current market price of Rs 48.
News in Focus


ICICI Securities has reiterated a Buy rating on Tata Power Company, maintaining a target price of Rs 485, implying 31% upside from the current market price of Rs 371.

ICICI Securities has maintained a Buy rating on Coforge Limited, setting a target price of Rs 1,950, implying a 17% upside from the current market price of Rs 1,669.

ICICI Securities has maintained a Buy rating on Bharat Electronics, setting a target price of Rs 530, implying a 35% upside from the current market price of Rs 394.

Axis Securities has maintained a Buy rating on NTPC, though it has trimmed the target price slightly to Rs 420 from Rs 430, implying a 20% upside from the current market price of Rs 350.

ICICI Securities has maintained a Buy rating on Steel Authority of India, setting a target price of Rs 225, implying a 36% upside from the current market price of Rs 165.
Main Regional Stories

Axis Securities has maintained its Buy rating on Bank of Baroda, though it has trimmed the target price to Rs 290 from Rs 315, implying an 18% upside from the current market price of Rs 246.6.

Axis Securities has reiterated a Buy rating on Greenply Industries Limited, raising its target price to Rs 355 from Rs 340, implying a 19% upside from the current market price of Rs 298.

Axis Securities has reiterated a Buy rating on SBI Life Insurance Limited, setting a target price of Rs 2,350, implying a 27% upside from the current market price of Rs 1,859.
Researchers claim to have revised the heart rate procedure, benchmarking a lower maximum for women.
According to health experts a few measures have been suggested in order to keep oneself hale and hearty.
t has been seen that women who has cycled for decreased their cycling time from more than 15 minutes a day to less than 15 minutes gained about four-and-a-half pounds on average.
It has been reported that organizers of Toronto's International Medical Marijuana Expo say they want to attract people tired of taking pharmaceutical drugs with adverse side-effects. 









